LD-2 disclosure · 2nd Quarter - Report

VOGEL GROUP ON BEHALF OF HEALTHCARE SUPPLY CHAIN ASSOCIATION

via CORCORAN STREET GROUP

2nd Quarter (Apr 1 - June 30) · 2024Posted Jul 22, 2024Filing document ↗LDA record ↗

Income$15Kfee reported

Client

Name: VOGEL GROUP ON BEHALF OF HEALTHCARE SUPPLY CHAIN ASSOCIATION
Description: HSCA is a trade association that represents group purchasing organizations.
Location: District of Columbia · United States of America

Registrant

Firm: CORCORAN STREET GROUP
Location: Washington, District of Columbia, United States of America

Lobbying activities

2 issues

Health Issues
Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy beneﬁt managers; Legislation related to drug shortages; S.1339 -Pharmacy Beneﬁt Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.
LobbyistsBRADLEY HOWARD · mr ALEXANDER NICHOLAS BLAIR
Covered position (BRADLEY HOWARD): Rep. Stephanie Murphy, Chief of Staff; U.S. Small Business Admin, Public Affairs & Media Manager; Blue Dog Coalition, Communications Dir; Rep. Mike Ross, Communications Dir
TargetedSENATE · HOUSE OF REPRESENTATIVES
Homeland Security
Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy beneﬁt managers; Legislation related to drug shortages; S.1339 -Pharmacy Beneﬁt Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.

LD-2 disclosure · 2nd Quarter - Report

VOGEL GROUP ON BEHALF OF HEALTHCARE SUPPLY CHAIN ASSOCIATION

via CORCORAN STREET GROUP

2nd Quarter (Apr 1 - June 30) · 2024Posted Jul 22, 2024Filing document ↗LDA record ↗

Income$15Kfee reported

Client

Name: VOGEL GROUP ON BEHALF OF HEALTHCARE SUPPLY CHAIN ASSOCIATION
Description: HSCA is a trade association that represents group purchasing organizations.
Location: District of Columbia · United States of America

Registrant

Firm: CORCORAN STREET GROUP
Location: Washington, District of Columbia, United States of America

Lobbying activities

2 issues

Health Issues
Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy beneﬁt managers; Legislation related to drug shortages; S.1339 -Pharmacy Beneﬁt Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.
LobbyistsBRADLEY HOWARD · mr ALEXANDER NICHOLAS BLAIR
Covered position (BRADLEY HOWARD): Rep. Stephanie Murphy, Chief of Staff; U.S. Small Business Admin, Public Affairs & Media Manager; Blue Dog Coalition, Communications Dir; Rep. Mike Ross, Communications Dir
TargetedSENATE · HOUSE OF REPRESENTATIVES
Homeland Security
Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, including drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management, Education related to differences between group purchasing organizations and pharmacy beneﬁt managers; Legislation related to drug shortages; S.1339 -Pharmacy Beneﬁt Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.